Is IBCR11 worth it? Analysis of BREI Integral CRI FII

Recommendation: NEUTRO COM RISCO ALTO · Rating 4.6/10

Analysis and recommendation

ALERT: Two troubled loans (representing 34% of net assets) are in judicial enforcement, and a unitholder holding 17.9% of the units wants to replace the manager—which could paralyze restructuring negotiations. IBCR11 buys CRIs (Brazilian real-estate receivables certificates—debt securities backed by real estate) indexed to IPCA, Brazil's official inflation index, and passes on the interest monthly, exempt from income tax. The manager, BREI, is a boutique firm specializing in higher-risk real estate credit—our model rates it as FAIR. The unit price has plunged 47% since the IPO (from R$ 100 to R$ 37) and the monthly distribution has fallen from R$ 1.50 (Jan/2022) to R$ 0.60—a 60% drop in four years—due to two ongoing defaults. The current distribution is on a razor's edge: the safety reserve has fallen to R$ 0.09 per unit and will be exhausted in about six months if nothing changes. Today's price (P/BV of 0.42—you pay R$ 42 for every R$ 100 of the fund's net assets) prices in the risk; it is not a guaranteed bargain, but rather the market pricing in two active defaults. It suits an aggressive profile with a 24-month horizon and the stomach for fluctuating distributions; it is not suitable for anyone who needs predictable income or is unfamiliar with real estate credit risk. Verdict: HOLD only as a satellite bet (3–5% of the portfolio) if you already understand what you are buying.

Investment thesis

IBCR11 is a concentrated bet on collateral recovery. The fund holds 11 IPCA+ CRIs with an HTM rate of 9.77%—a robust premium over the Selic policy rate—but the current thesis depends crucially on two specific variables: (1) success in enforcing the fiduciary lien on the CRVO property in São Leopoldo/RS (27% of net assets, collateral appraisal R$ 33.4M vs. outstanding balance R$ 23.2M); and (2) renegotiation or enforcement of the Olimpo CRI (7.2% of net assets, in default since Jan/2025). The 41% discount to book value is generous, but it is not arbitrage—it is the market pricing in enforcement risk. Anyone entering today is betting that the CRVO auction will clear close to the appraisal value and that Olimpo will be made whole through its collateral. Both scenarios require time (12–24 months) and tolerance for a DPU likely stuck at R$ 0.60–0.70 while recovery takes place.

Who it's for

Deep value investors willing to buy funds with active credit events
Aggressive profile with tolerance for technical default and a 24+ month horizon
Those who understand that the thesis is collateral enforcement, not stable dividend yield
Investors who already hold a high-grade paper portfolio (KNCR/AFHI) and want an additional premium via high yield

Who it's not for

Conservative investors who cannot tolerate DPU fluctuating by 60% (R$ 1.50 → R$ 0.60) over 4 years
Investors who confuse 'paper FII' with safe fixed income — IBCR11 is high-yield credit
Those seeking income predictability — reserves dropped from R$ 0.28 (Sep/25) to R$ 0.09 (Feb/26)
Profiles that do not accept a concentration of 38% in a single group (Tarjab/Pateo) and 27% in a single judicialized BTS

Points of attention and risks

CRVO CRI (27.3% of net assets) declared in early maturity

On January 23, 2026, the collateral manager Virgo declared early maturity for the CRVO operation (Unidasul BTS in São Leopoldo/RS) after months of waivers. Outstanding balance is R$ 23.2M (HTM). The debtor must deposit the full balance; if it fails to pay, the full fiduciary lien on the property will be enforced (2024 appraisal at R$ 33.4M). Rental collection (R$ 120k/month) remains regular via fiduciary assignment. The scenario stated by the manager is optimistic, but the process is judicial and auction liquidity is uncertain.

Olimpo CRI (7.2% of net assets) in default since Jan/2025

The Olimpo CRI (residential land subdivision/houses in SP) had a bullet amortization on January 22, 2025 that was not paid. It has 30% subordination, fiduciary lien on land (potential gross sales value of R$ 48M), additional receivables of R$ 28M, and guarantees. MTM jumped from 11% to 22.28% (strong discount to HTM of R$ 8.67M → MTM of R$ 6.14M, accounting loss of ~R$ 2.5M already recognized). Negotiations are underway; the appraisal of collateral exceeds the outstanding balance stated by management.

DPU lowered from R$ 0.70 (Dec/25) to R$ 0.60 (Jan–Mar/26)

Management cut the DPU by ~14% in early 2026, reflecting the impact of CRVO at a slower amortization pace (real estate asset income dropped from R$ 828k in Dec/25 to R$ 622k–684k in Jan–Feb/26). Retained earnings reserves plummeted from R$ 0.28 (Sep/25) to R$ 0.13 (Dec/25) and R$ 0.09 (Feb/26).

Geographic and developer concentration

Geography: 53% São Paulo, 28% RS, 18% SC, 0.1% ES — exposed to the regional real estate market. Concentration in the Tarjab/Pateo group (Pateo II + Pateo III + Vivatti + Maehara) developer: 4 CRIs from the same group in Presidente Prudente/SP account for ~37% of net assets. Restructuring of the Pateo assets in Jun/Jul/2024 raised the rate to IPCA + 13%/12.5%, but concentrates risk in a single originator.

Low liquidity — R$ 308k/day in Feb/26

Average daily volume in February 2026 was R$ 307,731 (12-month average even lower at R$ 191k/day since IPO). A significant position takes weeks to liquidate without moving the price. The unit has fallen 47.82% since the IPO (R$ 100 → R$ 52.18) with a peak in selling pressure in 2025.

Braspark CRI (5.8% of net assets) — restructuring approved via sale of property to GGRC11

At an extraordinary unitholders' meeting (Mar/2026), Braspark CRI unitholders approved the sale of the logistics property in Garuva/SC to the GGRC11 FII via the capitalization of ~R$ 200M in units. The debtor will sell the units on the secondary market (max. R$ 300k/day) and settle the CRI in 12 monthly installments starting from August 2026, with a new guarantee consisting of a fiduciary lien on GGRC11 units (coverage of 140% of the balance). The rate was renegotiated to IPCA + 9% + 2% premium. Positive: shortens the CRI's maturity by ~4 years and bolsters available cash for reallocation. Risk: depends on the tradable volume of GGRC11 on the secondary market.

Governance risk — concentrated unitholder (17.9%) requests removal of the BREI manager

In March 2026, a unitholder holding 17.9% of the units requested the calling of a General Meeting to: (1) dismiss the BREI manager in favor of IGUANA INVESTIMENTOS; (2) eliminate the performance fee; (3) transform the fund into a broad-mandate multi-strategy fund. BREI strongly opposed this, warning of the risk of work discontinuity in CRIs undergoing recovery. The outcome of the meeting will define the institutional future of the fund—if the replacement is approved, operational paralysis in CRVO+Olimpo negotiations could ensue.

41% discount to book value — opportunity or priced-in risk?

A P/BV of 0.55 (unit price R$ 49.00 vs. book value R$ 89.22 in Apr/26) makes it one of the most discounted in the high-yield paper subclass. The market is pricing in ongoing credit events (CRVO + Olimpo = 34.5% of net assets exposed to recovery) and a history of falling DPUs (R$ 1.50 in Jan/22 → R$ 0.60 in Apr/26, a 60% drop in 4 years). Convergence to book value requires resolving CRVO (the manager's favorite), management stability (preventing replacement at the unitholders' meeting), and DPU stabilization at the current range.

Is IBCR11 trustworthy?

Our current reading of IBCR11 is NEUTRO COM RISCO ALTO, with a score of 4.6/10. This score comes neither from the manager nor the administrator: it is Rico aos Poucos' editorial assessment, built from the documents the fund files with the CVM. Below is what supports it — and what argues against it.

Dois eventos de crédito ativos e relevantes: o CRI CRVO (27,3% do PL) teve vencimento antecipado decretado e o Olimpo está em default desde jan/2025. O DPS já foi cortado 14% e a liquidez é baixa (~R$ 308 mil/dia); o P/VP de 0,43 embute o risco, mas a tese depende de recuperação de garantias.

Is IBCR11 safe?

Safety in a REIT is not yes or no — it is how much risk you accept. IBCR11 has a alto risk profile. What that means in practice:

Component	Level
Concentração	3.5
Price volatility	2.0
Dividend volatility	4.5
Liquidez	4.0
Underlying asset risk	4.5
Financial risk / leverage	1.0

Risks that don't show up in IBCR11's fact sheet

Concentration in developer Tarjab/Pateo (38% of NAV)

The Pateo II + Pateo III + Vivatti + Maehara CRIs total 37.8% of NAV, and all share the same debtor group (Tarjab) operating in Presidente Prudente, São Paulo. Execution difficulty risk is correlated—a crisis in the group affects all 4 simultaneously.

Restructurings of the Pateos in Jun–Jul/2024 raised rates and reinforced collateral (fiduciary lien + fiduciary assignment of receivables + personal guarantees).

No published credit rating on any CRI

None of the 11 CRIs have an agency rating (Fitch, Moody's, S&P) disclosed in the management reports. Operations are originated via True/Virgo securitization companies without the traditional classification circuit. This reflects their genuine high-yield character but makes peer comparison difficult.

Loft with MTM of 1,685% over HTM

The Loft CRI has an MTM rate of 1,685.24%—signalling a deep discount to HTM (R$ 11.80M → MTM R$ 6.03M, cumulative accounting loss of ~R$ 5.7M). The operation is undergoing gradual divestment as inventory is sold.

The asset already has its certificate of occupancy and the properties are ready. Amortization will occur at the pace of divestments.

Retained earnings reserve at historical low (R$ 0.09/unit)

The reserve dropped from R$ 0.28 (Sep/25) to R$ 0.13 (Dec/25) and R$ 0.09 (Feb/26). Practically depleted—there is no longer a cushion to sustain the current DPU if monthly earnings drop below R$ 0.60.

DPU has already been cut to R$ 0.60 (from R$ 0.70 in Dec/25), incorporating the revenue loss from CRVO.

Accounting maturity of the Olimpo CRI has already passed (Jan 22, 2025)

The bullet maturity of the Olimpo CRI occurred on January 22, 2025, more than 15 months ago, without payment. The fund has carried the asset on its NAV since then via collateral foreclosure. The displayed accounting duration (32.69 years) is an MTM distortion, not real economic duration.

Management reports that the collateral appraisal exceeds the outstanding balance (additional receivables R$ 28M + fiduciary lien on land with gross development value of R$ 48M).

Scenarios for IBCR11

Scenario	Description
CRVO auction close to appraisal value (R$ 33M)	The property is auctioned off judicially for an amount close to the appraisal (R$ 33M vs. outstanding balance of R$ 23M), releasing R$ 10M in accounting upside for the fund + capital to reallocate into new CRIs with cap rates of 13%+
Olimpo recovers via collateral	Negotiation with Olimpo converts into payment via collateral foreclosure (additional receivables R$ 28M + fiduciary lien on land with gross development value of R$ 48M exceed the CRI's R$ 8.67M balance). Restores MTM and stabilizes DPU.
Selic falls to 11% and discount to BV closes	Focus survey scenario of Selic at 11% in 12 months + drop in high-yield risk premium with the resolution of CRVO compresses the discount to 20–25% to book value (unit price R$ 67–72).
CRVO auction below outstanding balance	The judicial auction market in Rio Grande do Sul post-floods is fragile. Specialized build-to-suit property (Unidasul grocery store) has a limited buyer pool. If sold for R$ 18–20M, there is an accounting loss of R$ 3–5M vs. the outstanding balance.
Default in Tarjab asset spikes concentration	If any of the 4 Tarjab group CRIs (Pateo II/III + Vivatti + Maehara, 38% of NAV) defaults, it compounds current events and pushes the fund to >50% of NAV in restructuring/recovery—DPU drops to the R$ 0.40–0.50 range.
CRVO foreclosure drags on for 36+ months	Brazilian judicial foreclosure processes for real-estate fiduciary liens can take 24–48 months. The fund operates with DPU locked at R$ 0.60 and over 25% of NAV immobilized in recovery for 3 years.

Conclusion

The IBCR11 is a high-yield Brazilian REIT-style fund (FII) currently undergoing a real management stress test. The fund was incepted in Aug/2021 with 802,921 units at R$ 100 and a R$ 80.3M capital raise, stabilizing around R$ 86M in net assets with 11 IPCA+-indexed CRIs (Brazilian real-estate receivables certificates) across residential, build-to-suit, land subdivision, and logistics sectors, a hold-to-maturity (HTM) rate of 9.77% p.a., and a 6.54-year duration.

Today, the portfolio concentrates two relevant credit events: the CRVO CRI (27.3% of net assets, Unidasul build-to-suit in São Leopoldo, Rio Grande do Sul) with early maturity declared on Jan 23, 2026, after RS floods compromised the borrower's capacity; and the Olimpo CRI (7.2% of net assets, land subdivision) in default since Jan 22, 2025. Management (BREI) states that the collateral for both exceeds the outstanding balance—CRVO appraisal at R$ 33.4M vs. R$ 23.2M balance—but judicial enforcement takes time.

On the other hand, the current position offers interesting characteristics: a P/BV of 0.59 (a 41% discount), a 13.6% dividend yield sustained by a stabilized DPS of R$ 0.60/month since Jan/26, no leverage at the fund level (0% LTV), 100% IPCA+ indexation, and a 4-5 pp premium over high-yield peers. The macroeconomic scenario is favorable (Focus survey projects the Selic rate at 11% in 12 months vs. 14.75% currently), which typically reprices discounted FIIs.

The main risk is time: undistributed retained earnings dropped to R$ 0.09/unit (a historical low), and current cash earnings (R$ 0.55-0.61) are already below the distributed DPS (R$ 0.60). If the CRVO auction takes place in 6-9 months close to the appraisal value, there is meaningful upside (R$ 10M to reallocate + extraordinary distribution). If it takes 24+ months, management will need to cut the DPS to R$ 0.50.

Frequently asked questions

Is IBCR11 good? Is it worth investing?

Current recommendation: NEUTRO COM RISCO ALTO. Rating 4.6/10. ALERT: Two troubled loans (representing 34% of net assets) are in judicial enforcement, and a unitholder holding 17.9% of the units wants to replace the manager—which could paralyze restructuring negotiations. IBCR11 buys CRIs (Brazilian real-estate receivables certificates—debt…

IBCR11: buy or sell?

Our current read on IBCR11 is “NEUTRO COM RISCO ALTO”. Rating 4.6/10. Assess it against your risk profile and the points of attention listed above.

What are IBCR11's risks?

The main points of attention for BREI Integral CRI FII include: CRVO CRI (27.3% of net assets) declared in early maturity; Olimpo CRI (7.2% of net assets) in default since Jan/2025; DPU lowered from R$ 0.70 (Dec/25) to R$ 0.60 (Jan–Mar/26); Geographic and developer concentration.

Who is IBCR11 suitable for?

IBCR11 is suitable for: Deep value investors willing to buy funds with active credit events Aggressive profile with tolerance for technical default and a 24+ month horizon Those who understand that the thesis is collateral enforcement , not stable dividend yield